Early Prosthetics in Children With Upper Limb Deficiency (EARLIMB)

April 14, 2021 updated by: University Hospital, Lille

Adaptative Motor Behavior of Children With Unilateral Upper Limb Deficiency After Early Prosthetics.

For children with congenital upper limb deficiency, introduction of the prosthesis is guided by clinical experience rather than by Evidence Based Medicine.

This study will assess early development in children with upper limb deficiency according to age at the introduction of the prosthesis.

This study will give new keys in these specific prosthesis cares.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Villeneuve-d'Ascq, France
        • SSR pédiatrique Marc Sautelet
        • Contact:
          • Phone Number: 0328800770

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 month to 3 months (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Child with unilateral upper limb agenesis

Description

Inclusion Criteria:

  • Male or female child
  • Aged from 1 month to 3 months and a half
  • Placement of a prosthesis in a patient with isolated upper limb deficiency, type of congenital transverse unilateral amputation of the forearm segment
  • Socially insured patient,
  • Patient willing to comply with all study procedures and study duration
  • Written informed consent from patient's legal guardians

Exclusion Criteria:

  • Children with one or more high risk factors for neurodevelopmental disorders:

    • Very prematurity (<32 weeks of amenorrhea [SA])
    • Premature infants <37 WA with intrauterine growth retardation (IUGR) or low weight for gestational age (PAG) <3rd percentile or <- 2 SD for GA and sex according to national reference curves)
    • A presumed hypoxo-ischemic encephalopathy with an indication of therapeutic hypothermia
    • A perinatal arterial cerebrovascular accident (AVC) (diagnosed between the 20th week of fetal life and the 28th day of life including in premature newborns).
    • Cerebral growth anomalies: microcephaly with cranial perimeter <- 2 SD at birth verified secondarily or macrocephaly> + 3 SD for the term (persisting after a second measurement).
    • A family history of severe first-degree neurodevelopmental disorder (brother or sister or parent)
    • Symptomatic congenital cytomegalovirus infections and other infectious fetopathies: toxoplasmosis, Zika, rubella, etc.
    • Bacterial and viral herpetic meningoencephalitis
    • Complex congenital heart disease operated on: transposition of the large vessels; left ventricular hypoplastic syndrome.
    • Perinatal exposure to a major toxicant: certain antiepileptics (sodium valproate); severe exposure to alcohol and / or with signs of fetal disease.
    • Major, prolonged and repeated surgery (cardiac, cerebral, abdominal, thoracic).
  • Exclusion of all deficiency forming part of a polymalformative, vascular syndrome (Poland syndrome), genetic cause ...
  • Exclusion of all other forms of agenesis (bilateral, longitudinal, persistence of hand remains),
  • Refusal of consent from one or both parents

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Early introduction
Casting and delivery of a cosmetic upper limb prosthesis at 3-4 months old of age.
Casting and delivery of a cosmetic upper limb prosthesis at 3-4 months old of age.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Vineland Adaptive Behavior Scales version II Motor skills Domain score Motor skills Domain score
Time Frame: at 24 months old
at 24 months old

Secondary Outcome Measures

Outcome Measure
Time Frame
Assisting Hand Assessment
Time Frame: at 3 years old
at 3 years old
Communication Domain Score
Time Frame: at 9 months old , at 24 months old
at 9 months old , at 24 months old
Daily living skills Domain Score at 9 and 24 months old
Time Frame: at 9 months old , at 24 months old, at 3 years old
at 9 months old , at 24 months old, at 3 years old
Socialization Domain score
Time Frame: at 9 months old , at 24 months old, at 3 years old
at 9 months old , at 24 months old, at 3 years old
Motor skills Domain score
Time Frame: at 9 months old
at 9 months old

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Alice TAQUET, MD, University Hospital, Lille

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

May 1, 2021

Primary Completion (Anticipated)

May 1, 2026

Study Completion (Anticipated)

May 1, 2026

Study Registration Dates

First Submitted

April 14, 2021

First Submitted That Met QC Criteria

April 14, 2021

First Posted (Actual)

April 20, 2021

Study Record Updates

Last Update Posted (Actual)

April 20, 2021

Last Update Submitted That Met QC Criteria

April 14, 2021

Last Verified

February 1, 2021

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Limb Deficiencies

Clinical Trials on prosthesis

Subscribe